Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies against GPCR Targets

NEXT STORY
Teladoc Health Improves Access to Whole-Person Care Through an Expanded Partnership with National Labor Alliance
PREV STORY
Quipt Home Medical Announces Record Preliminary Fourth Quarter 2021 Results and Provides a Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

INNATE PHARMA : Publication of monalizumab research in the prestigious “Cell” journal

Innate Pharma announces publication of monalizumab research in the prestigious "Cell" journal widening the ...

author_avatar
NASDAQ Market News

PetLife Pharmaceuticals Rebrands all Products in Preparation for The FDA Registration Process

Hancock, MD, Aug. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) a ...

author_avatar
NASDAQ Market News

Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock

MEDFORD, N.Y., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ:CEMI) (“Chembio”), a ...

author_avatar
NASDAQ Market News